drugset / Trial / NCT00003001

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

NCT00003001

Phase 1/2 Unknown 63 enrolled Stony Brook University
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy consisting of fluorouracil, leucovorin, and gemcitabine in treating patients with recurrent or metastatic colorectal cancer.

Timeline

Start
1997-04
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule
Subject Leucovorin Small molecule Intravenous
Subject fluorouracil Small molecule

Indications